February 17, 2026
Sensorion Announces Leadership Changes
Nawal Ouzren Chief Executive Officer to step down for personal reasons Amit Munshi, Chairman of Sensorion to assume role of…
Pharmaceuticals, Biotechnology and Life Sciences
Nawal Ouzren Chief Executive Officer to step down for personal reasons Amit Munshi, Chairman of Sensorion to assume role of…
Ad hoc announcement pursuant to Art. 53 LR Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond…
CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value RESEARCH TRIANGLE…
LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based…
A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC)…
– MAJESTY, the first global Phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at…
Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today…
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount…
Submission marks key step in study of mesenchymal stem cell therapy to treat symptomatic cartilage defects in patients with knee…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro #cns–Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel…